These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32811441)

  • 1. Analysis of β-catenin association with obesity in African Americans with premalignant and malignant colorectal lesions.
    Shokrani B; Brim H; Hydari T; Afsari A; Lee E; Nouraie M; Sherif Z; Ashktorab H
    BMC Gastroenterol; 2020 Aug; 20(1):274. PubMed ID: 32811441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
    Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
    JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues.
    Akyol A; Güner G; Özşeker HS; Işık A; Atcı Ö; Uzun S; Atayar E; Ozaltin F; Gedikoğlu G; Sökmensüer C; Fearon ER
    Lab Invest; 2019 Jan; 99(1):128-137. PubMed ID: 30177831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of colorectal carcinoma diseases with activation of Wnt/beta-catenin signalling pathway using hierarchical clustering approach.
    Mosnier JF; Airaud F; Métairie S; Volteau C; Bezieau S; Denis M
    J Clin Pathol; 2022 Mar; 75(3):168-175. PubMed ID: 33441391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The majority of β-catenin mutations in colorectal cancer is homozygous.
    Arnold A; Tronser M; Sers C; Ahadova A; Endris V; Mamlouk S; Horst D; Möbs M; Bischoff P; Kloor M; Bläker H
    BMC Cancer; 2020 Oct; 20(1):1038. PubMed ID: 33115416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.
    Morikawa T; Kuchiba A; Lochhead P; Nishihara R; Yamauchi M; Imamura Y; Liao X; Qian ZR; Ng K; Chan AT; Meyerhardt JA; Giovannucci E; Fuchs CS; Ogino S
    Cancer Res; 2013 Mar; 73(5):1600-10. PubMed ID: 23442321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
    Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
    Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer.
    Uzun S; Isik A; Katipoglu K; Guner G; Akyol A
    In Vivo; 2023; 37(4):1576-1583. PubMed ID: 37369481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.
    Fan XS; Wu HY; Yu HP; Zhou Q; Zhang YF; Huang Q
    Int J Colorectal Dis; 2010 May; 25(5):583-90. PubMed ID: 20195621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer.
    Chen X; Wang C; Jiang Y; Wang Q; Tao Y; Zhang H; Zhao Y; Hu Y; Li C; Ye D; Liu D; Jiang W; Chin EY; Chen S; Liu Y; Wang M; Liu S; Zhang X
    Signal Transduct Target Ther; 2020 May; 5(1):52. PubMed ID: 32355204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the clinical utility of Wnt pathway markers in colorectal cancer.
    Veloudis G; Pappas A; Gourgiotis S; Falidas E; Dimitriou N; Karavokiros I; Aggelou A; Komborozos V; Petraki C; Menounos P; Bramis I; Bastounis E; Pikoulis E
    J BUON; 2017; 22(2):431-436. PubMed ID: 28534366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.
    Herstad KMV; Gunnes G; Rørtveit R; Kolbjørnsen Ø; Tran L; Skancke E
    BMC Vet Res; 2021 Mar; 17(1):119. PubMed ID: 33712002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.